^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    MET N375S

    i
    Other names: DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase
    Entrez ID:
    4233
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others
    Apply
    A Biomarker-implemented Clinical Study Evaluating Mutations in MET and TP53 in a Population of Treatment-refractory Squamous Cell Carcinoma (NCT04533321)
    Phase 2
    National University Hospital, Singapore
    Not yet recruiting
    Last update posted :
    08/31/2020
    Initiation :
    09/01/2020
    Primary completion :
    09/01/2023
    Completion :
    09/01/2023
    TP53 • MET
    |
    TP53 mutation • HER-2 amplification • MET amplification • MET mutation • MET N375S • HER-2 amplification + MET amplification
    |
    Gilotrif (afatinib)
    Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma (NCT03938012)
    Phase N/A
    National University Hospital, Singapore
    Recruiting
    Last update posted :
    05/06/2019
    Initiation :
    10/03/2017
    Primary completion :
    10/01/2021
    Completion :
    10/01/2022
    TP53 • MET
    |
    TP53 mutation • HER-2 amplification • MET amplification • MET mutation • MET N375S • HER-2 amplification + MET amplification